OakChart

Twist Bioscience Corp

TWSTHealthcare·Biotechnology·USA·Mid·NASD·Nov 11 • 3:59 PM ET

122.59-9.54 (-7.22%)
2026-11-12 01:13 CET
Market cap
8,698.43 USD m
Revenue, TTM
431.80 USD m
Net income, TTM
-136.72 USD m
Free cash flow, TTM
-93.12 USD m
EPS diluted, TTM
-2.22
P/E
-
Compare

Price

TWST against its 20, 50 and 200-day averages
2050200missearnings
50.00100.00150.00200.004.3M8.6MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26TWSTclose 122.5920-day 141.6250-day 150.90200-day 92.53122.5952w high

44.2% under the 52-week high of 219.71 on 6 Oct 2026. 52-week low 23.30 on 14 Nov 2025. Last 15 sessions, 53.2% high to low

Volume 1.50× normal · the line is the 50-bar volume average

Profile

TWST
52-week range, 51% of the way up
23.30219.71

Twist Bioscience Corp. engages in the development of a proprietary semiconductor-based synthetic DNA manufacturing process. It operates through the following geographical segments: Americas, EMEA, and APAC. The Americas segment consists of the United States of America, Canada, Mexico, and South America. The EMEA segment includes Europe, Middle East, and Africa. The APAC segment focuses on Japan, China, South Korea, India, Singapore, Malaysia, and Australia. The company was founded by William Marine Banyai, Emily Marine Leproust, and Bill James Peck in 2013 and is headquartered in San Francisco, CA.

IndexRUT
Employees979
IPOOct 31, 2018
Beta2.24
ATR, 14d16.70
Rel volume1.50
Short float15.37%
Insider own2.77%
Inst own118.55%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap8.07B
Enterprise Value8.00B
Income-136.72M
Sales431.80M
Book/sh7.11
Cash/sh2.53
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees979
IPOOct 31, 2018

Ratios

P/E-
Forward P/E-
PEG-
P/S18.69
P/B17.24
P/C48.37
P/FCF-
EV/EBITDA-
EV/Sales18.52
Quick Ratio2.38
Current Ratio2.67
Debt/Eq0.21
LT Debt/Eq0.19
Option/ShortYes / Yes

Earnings

EPS (ttm)-2.22
EPS next Y-1.33
EPS next Q-0.39
EPS this Y-65.13%
EPS next Y38.09%
EPS next 5Y12.43%
EPS past 3/5Y31.51% 18.31%
Sales past 3/5Y22.76% 33.11%
EPS Y/Y TTM-53.86%
Sales Y/Y TTM19.19%
EPS Q/Q-268.48%
Sales Q/Q23.24%
EarningsNov 12 BMO
EPS/Sales Surpr.-10.61% 3.37%

Ownership

Insider Own2.77%
Insider Trans-35.65%
Inst Own118.55%
Inst Trans4.37%
ROA-20.78%
ROE-29.59%
ROIC-25.76%
Gross Margin51.97%
Oper. Margin-31.91%
Profit Margin-31.66%
SMA20-13.44%
SMA50-18.76%
SMA20032.49%
Trades-

Technical

Shs Outstand65.83M
Shs Float64.01M
Short Float15.37%
Short Ratio4.24
Short Interest9.84M
52W High219.71 -44.20%
52W Low23.30 426.14%
Volatility11.91% 10.81%
ATR (14)16.70
RSI (14)41.37
Beta2.24
Rel Volume1.50
Avg Volume2.32M
Volume3,479,271

Performance

Perf Week-14.02%
Perf Month-18.99%
Perf Quarter-2.16%
Perf Half Y125.39%
Perf YTD286.48%
Perf Year291.41%
Perf 3Y626.67%
Perf 5Y5.41%
Perf 10Y-
Recom1.92
Target Price168.25
Prev Close132.13
Price122.59
Change %-7.22%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 08, 2026InitiatedJJefferiesHold$150+22.4%
Sep 09, 2026InitiatedUUBSNeutral$144+17.5%
Sep 09, 2026InitiatedBBWS FinancialSell$45-63.3%
Jul 06, 2026DowngradeEEvercore ISIOutperform → In-line$102-16.8%
Jun 15, 2026InitiatedCCanaccord GenuityBuy$90-26.6%
May 05, 2026UpgradeLLeerink PartnersMarket Perform → Outperform$70-42.9%
Nov 04, 2025InitiatedSStephensOverweight$41-66.6%
Dec 13, 2024InitiatedWWolfe ResearchOutperform$60-51.1%
Jun 04, 2024InitiatedGGuggenheimBuy$53-56.8%
Jan 17, 2024UpgradeGGoldmanNeutral → Buy$25 → $45-63.3%

Peers

Mkt cap
TickerCompanyMkt cap
MRVIMaravai LifeSciences Holdings Inc2.00B
AAgilent Technologies Inc49.89B
DNAGinkgo Bioworks Holdings Inc679.14M
TECHBio-Techne Corp11.44B
DHRDanaher Corp165.55B
ILMNIllumina Inc32.20B
QGENQiagen NV10.39B
TMOThermo Fisher Scientific Inc265.92B
CDXSCodexis Inc106.93M
TXG10x Genomics Inc8.08B

Insider trading

latest 14 of 100
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Cho DennisSee RemarksNov 03 '26Sale135.40949128,49662,840Nov 05 04:05 PM
Finn Patrick JohnPresident and COONov 03 '26Sale135.402,565347,306180,278Nov 05 04:05 PM
Leproust Emily M.Chief Executive OfficerNov 03 '26Sale135.404,573619,193558,187Nov 05 04:05 PM
WERNER ROBERT F.Chief Accounting OfficerNov 03 '26Sale135.4014820,03942,769Nov 05 04:05 PM
Green PaulaSVP of Human ResourcesNov 03 '26Sale135.401,007136,350105,625Nov 05 04:05 PM
WERNER ROBERT F.OfficerNov 03 '26Proposed Sale135.4014820,039Nov 03 03:24 PM
Finn Patrick JohnOfficerNov 03 '26Proposed Sale135.402,565347,305Nov 03 03:21 PM
Cho DennisOfficerNov 03 '26Proposed Sale135.40949128,496Nov 03 03:21 PM
Leproust Emily M.OfficerNov 03 '26Proposed Sale135.404,573619,192Nov 03 03:19 PM
Green PaulaOfficerNov 03 '26Proposed Sale135.401,007136,350Nov 03 03:16 PM
Finn Patrick JohnPresident and COOOct 23 '26Sale134.592,245302,152182,843Oct 27 04:05 PM
Finn Patrick JohnOfficerOct 23 '26Proposed Sale134.592,245302,153Oct 23 03:15 PM
Laponis AdamChief Financial OfficerOct 09 '26Sale156.302,462384,82398,114Oct 13 04:05 PM
Laponis AdamOfficerOct 09 '26Proposed Sale156.302,462384,823Oct 09 03:12 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
IWMiShares Russell 2000 Index FundAUM: 77.38B
ARKEARK DIET Q3 Buffer ETFAUM: 1.45M
ARKKARK Innovation ETFAUM: 5.97B
ARKGARK Genomic Revolution ETFAUM: 1.97B
XBIState Street SPDR S&P Biotech ETFAUM: 10.50B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.34B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWOiShares Russell 2000 Growth ETFAUM: 14.06B

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q42026-11-12--0.387--123.5510
2026Q32026-08-03-0.560-0.506-0.560118.4114.558
2026Q22026-05-04-0.710-0.477-0.713110.72107.6410
2026Q12026-02-02-0.500-0.424-0.500103.7101.8810
2025Q42025-11-14-0.450-0.415-0.44999.0197.3310
2025Q32025-08-040.330-0.5190.33396.0695.619
2025Q22025-05-05-0.660-0.548-0.65992.7991.9911
2025Q12025-02-03-0.530-0.625-0.53488.7186.9611
2024Q42024-11-18-0.590-0.714-0.59284.7182.7110
2024Q32024-08-02-1.470-0.764-1.47281.4677.4011
2024Q22024-05-02-0.790-0.816-0.78775.3070.709
2024Q12024-02-02-0.750-0.777-0.74871.5067.599
2023Q42023-11-17-0.810-0.919-0.80766.9563.359
2023Q32023-08-04-1.010-1.125-1.00663.7460.629
2023Q22023-05-05-1.040-1.126-1.04260.1856.649
2023Q12023-02-03-0.740-1.134-0.74154.2454.418

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2019FY-3.920-3.778-3.92154.3952.81
2020FY-3.570-3.546-3.57190.1080.88
2021FY-3.150-3.136-3.152132.33130.95
2022FY-4.040-4.394-4.043203.57202.91
2023FY-3.600-3.718-3.597245.11241.58
2024FY-3.600-3.717-3.598312.97310.91
2025FY-1.300-1.313-1.300376.57374.81
2026FY--2.147--456.36
2027FY--1.329--548.62
2028FY--0.873--645.84
2029FY--0.062--773.47
2030FY-0.935--1,011

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-091100123.55123.08124.3
2026Q4S2026-11-061100123.54123.08124.3
2026Q4S2026-10-301100123.55123.08124.3
2026Q4S2026-10-221100123.59123.08124.3
2026Q4S2026-10-171100123.59123.08124.3
2026Q4S2026-10-161190123.59123.08124.3
2026Q4S2026-10-121190123.59123.08124.3
2026Q4S2026-10-091190123.54123.08124.3
2026Q4S2026-10-071190123.54123.08124.3
2026Q4S2026-10-061190123.54123.08124.3
2026Q4S2026-09-161090123.57123.2124.3
2026Q4S2026-09-081090123.51123.2124
2026Q4S2026-09-07990123.5123.2124
2026Q4S2026-08-03990123.5123.2124

Estimate history

EPS, annual-2.168-2.677-3.921-3.571-3.152-4.043-3.597-3.598-1.299-2.2237
Period201720182019202020212022202320242025TTM
EPS, quarterly-1.472-0.592-0.534-0.6590.333-0.449-0.5-0.713-0.562
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual10.76725.42754.38590.1132.333203.565245.109312.974376.572431.8
Period201720182019202020212022202320242025TTM
Sales, quarterly81.46484.7188.71392.79396.05799.009103.698110.715118.376
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual27.3626.6132.87345.08349.49956.52357.55758.87760.63162.674
Period201720182019202020212022202320242025MRQ
Shares, quarterly58.51958.87759.58259.85760.17460.63161.27462.15462.674
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue431.80376.57312.97245.11203.56132.3390.1054.3825.43
Cost of Goods Sold Incl. D&A207.41185.57179.62155.38119.3380.6261.4147.4332.19
Gross Profit224.38191.00133.3589.7384.2351.7128.696.96-6.76
Selling, General and Administrative Excl. Other362.16327.26309.25296.63333.26204.97146.27115.8163.80
Research and Development71.8680.2890.85106.89120.3169.0743.0135.6820.35
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income-137.77-136.26-175.90-206.90-249.02-153.26-117.58-108.85-70.56
Interest Expense0.000.000.030.010.080.370.791.291.31
Unusual Expense7.210.0044.9310.26-14.24-0.5322.50-0.01
Net Income Before Taxes-135.85-76.95-208.17-203.47-228.27-154.03-139.55-107.38-70.99
Income Taxes0.860.720.561.15-10.41-1.930.380.290.24
Consolidated Net Income-136.72-77.67-208.73-204.62-217.86-152.10-139.93-107.67-71.24
Net Income From Continuing Operations-136.72-77.67-208.73-204.62-217.86-152.10-139.93-107.67-71.24
Net Income-136.72-77.67-208.73-204.62-217.86-152.10-139.93-107.67-71.24
EPS (Recurring)-2.11-1.30-3.06-3.47-4.23-3.16-3.17-3.92-2.68
EPS (Basic, Before Extraordinaries)-2.22-1.30-3.60-3.60-4.04-3.15-3.57-3.92-2.68
EPS (Diluted)-2.22-1.30-3.60-3.60-4.04-3.15-3.57-3.92-2.68
EBITDA-112.38-111.41-144.47-177.59-212.38-141.27-110.90-102.54-64.83
Non-Operating Income (Expense)9.1259.3112.6913.706.58-0.941.322.770.89
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense52.5150.9240.2323.9262.4427.0112.488.152.34
Price To Sales Ratio14.874.478.384.709.3339.0033.0412.06-
Gross Margin51.9750.7242.6136.6141.3839.0831.8512.80-26.59
Operating Margin-31.91-36.18-56.20-84.41-122.33-115.81-130.50-200.15-277.50
Net Margin-31.66-20.63-66.69-83.48-107.02-114.94-155.31-197.98-280.16
Shares Outstanding62.6760.6358.8857.5656.5249.5045.0832.8726.61
Market Capitalization8,698.438,698.432,646.921,162.851,986.255,272.773,393.05777.51772.30

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue118.38110.72103.7099.0196.0692.7988.7184.71
Cost of Goods Sold Incl. D&A55.9253.5949.7348.1744.7646.7745.8746.48
Gross Profit62.4557.1253.9750.8451.3046.0342.8438.23
Selling, General and Administrative Excl. Other98.7395.7886.8780.7781.4287.5977.4874.28
Research and Development18.0219.7017.1317.0118.0523.9221.3121.13
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-36.28-38.66-32.90-29.93-30.12-41.56-34.64-36.04
Interest Expense0.000.000.000.00-0.140.020.03
Unusual Expense0.007.210.000.000.000.000.000.00
Net Income Before Taxes-34.74-43.98-30.25-26.8820.58-39.15-31.50-34.75
Income Taxes0.310.040.250.260.190.170.10-0.10
Consolidated Net Income-35.05-44.02-30.51-27.1420.39-39.33-31.59-34.66
Net Income From Continuing Operations-35.05-44.02-30.51-27.1420.39-39.33-31.59-34.66
Net Income-35.05-44.02-30.51-27.1420.39-39.33-31.59-34.66
EPS (Recurring)-0.56-0.63-0.50-0.450.33-0.66-0.53-0.59
EPS (Basic, Before Extraordinaries)-0.56-0.71-0.50-0.450.34-0.66-0.53-0.59
EPS (Diluted)-0.56-0.71-0.50-0.450.33-0.66-0.53-0.59
EBITDA-29.50-32.24-26.71-23.93-24.32-35.16-28.26-29.39
Non-Operating Income (Expense)1.541.892.653.0550.702.553.171.32
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.3614.9610.4912.7112.6916.069.479.75
Price To Sales Ratio14.877.164.954.526.216.748.338.45
Gross Margin52.7651.5952.0551.3553.4049.6048.2945.13
Operating Margin-30.65-34.92-31.73-30.23-31.36-44.79-39.05-42.55
Net Margin-29.61-39.76-29.42-27.4121.23-42.38-35.61-40.91
Shares Outstanding62.6762.1561.2760.6360.1759.8659.5858.88
Market Capitalization8,698.432,913.531,939.611,698.562,204.312,341.902,766.022,646.92

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments232.43276.40336.41504.97477.86290.00138.1980.7662.20
Short Term Receivables57.3234.9044.0640.2928.5526.3812.105.422.35
Inventories28.3124.0832.0639.3131.8012.297.336.031.83
Other Current Assets14.9011.4011.7211.918.286.202.513.471.49
Total Current Assets332.97346.78424.26596.48546.50334.87160.1395.6767.87
Net Property, Plant & Equipment151.66161.35203.36214.39105.7059.1620.8412.3314.83
Total Investments and Advances56.714.342.811.571.530.580.580.580.20
Long-Term Note Receivable1.80--0.00-----
Intangible Assets95.62100.29140.29145.5540.701.451.651.852.06
Other Assets3.101.575.683.387.672.823.805.360.69
Total Assets641.86614.32776.40961.38702.10398.88186.99115.7985.66
Short Term Debt Incl. Current Port. of LT Debt13.8214.8014.9013.649.779.743.332.500.00
Accounts Payable11.091.6314.0520.0914.904.839.767.532.85
Income Tax Payable4.542.734.373.662.44----
Other Current Liabilities61.9551.8540.0053.2735.9521.4617.268.516.63
Total Current Liabilities91.4171.0173.3290.6663.0536.0330.3518.549.48
Long Term Debt61.7570.2279.1781.2753.1626.244.407.229.15
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Other Liabilities15.750.410.470.065.070.350.160.970.75
Total Liabilities168.90141.63152.97171.99121.2862.6234.9126.7319.38
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.00290.48199.63
Common Equity472.96472.69623.43789.38580.82336.26152.08-201.42-133.36
Total Shareholders Equity472.96472.69623.43789.38580.82336.26152.0889.0666.28
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity472.96472.69623.43789.38580.82336.26152.0889.0666.28
Total Liabilities & Stockholders Equity641.86614.32776.40961.38702.10398.88186.99115.7985.66
Book Value Per Share7.808.0310.8313.9711.737.464.63-7.57-4.87
Tangible Book Value Per Share6.226.338.3911.3910.917.434.58-7.64-4.95
Full-Time Employees979923919989652525414289-
Price to Book Ratio18.585.381.772.529.1210.195.164.38-
Return on Assets-12.37-30.02-23.55-26.19-27.63-47.77-71.12-70.72-73.17
Return on Equity-16.43-38.08-28.97-31.80-33.17-57.31-89.30-91.72-95.89
Return on Invested Capital-14.53-38.45-29.12-25.02-23.99-38.60-68.81-73.99-78.63
Quick Ratio3.334.545.356.158.168.955.034.846.97
Current Ratio3.644.885.796.588.679.295.285.167.16

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-136.72-77.67-208.73-204.62-217.86-152.10-139.93-107.67-71.24
Depreciation25.3924.8531.4329.3136.6411.996.686.115.73
Other Funds (Non Cash)66.0217.8097.7933.8462.1937.2416.1810.623.56
Funds from Operations-45.31-35.02-79.50-141.47-119.03-102.86-117.08-90.93-61.94
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-7.76-12.6115.41-1.01-5.36-9.38-25.183.00-4.22
Cash from Operating Activities-53.07-47.63-64.09-142.47-124.39-112.24-142.25-87.94-66.16
Capital Expenditures-40.15-28.00-5.08-27.78-101.86-27.06-9.87-14.76-3.69
Net Assets From Acquisitions-5.000.000.000.00-8.16-0.480.000.000.00
Sale of Fixed Assets and Businesses0.002.500.000.000.000.000.000.020.02
Purchase or Sale of Investments-0.090.742.0078.39-117.16183.70-104.78-90.0730.54
Purchase of Investments-59.60-49.39-51.91-76.34-217.64-58.80-202.88-177.57-3.96
Sale Or Maturity of Investments59.5150.1353.91154.74100.48242.4998.1087.5034.50
Other Uses0.000.000.000.00-5.750.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-45.24-24.76-3.0750.61-232.93156.16-114.65-104.8126.87
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock13.8013.546.890.91272.09332.51307.06161.0888.82
Repurchase of Common Pref Stock-0.02-0.02-3.98-4.41-7.75-10.85-2.420.000.00
Sale of Common Pref Stock13.8113.5610.875.32279.85343.36309.49161.0888.82
Proceedsfrom Stock Options4.144.213.773.94273.83328.81298.99158.9188.82
Issuance or Reduction of Debt, Net0.000.000.000.00-1.56-3.33-3.33-2.500.00
Change in Long Term Debt0.000.000.000.00-1.56-3.33-3.33-2.500.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.00-1.56-3.33-3.33-2.500.00
Net Financing Active Other Cash Flow0.0015.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities13.8028.546.890.91270.53329.18303.73158.5888.82
Exchange Rate Effect0.180.140.13-0.03-0.320.020.020.03-
Net Change in Cash-84.34-43.71-60.15-90.98-87.10373.1146.85-34.1449.53
Free Cash Flow-93.12-75.63-69.17-170.25-226.24-139.31-152.12-102.69-69.85
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments166.84171.67197.95232.43250.80257.15
Short Term Receivables65.7665.0550.8657.3251.0551.15
Inventories35.1633.5232.9228.3125.9420.86
Other Current Assets53.5453.2022.1514.9011.999.29
Total Current Assets321.30323.44303.88332.97339.78338.44
Net Property, Plant & Equipment180.62181.88177.38151.66147.20151.21
Total Investments and Advances70.2270.2756.7356.7156.874.04
Intangible Assets94.9295.1995.3695.6295.8899.76
Other Assets5.385.432.933.102.182.17
Total Assets672.44676.21638.09641.86643.61595.62
Short Term Debt Incl. Current Port. of LT Debt8.6310.4412.2413.8215.5015.22
Accounts Payable17.0414.6812.4911.0911.988.06
Income Tax Payable7.384.983.904.544.254.09
Other Current Liabilities87.2189.8851.8061.9555.3347.61
Total Current Liabilities120.25119.9880.4491.4187.0774.98
Long Term Debt84.9685.4085.8161.7562.6565.08
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities21.4815.7515.7415.7515.6915.45
Total Liabilities226.70221.12181.99168.90165.41155.51
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity445.74455.09456.10472.96478.20440.11
Total Shareholders Equity445.74455.09456.10472.96478.20440.11
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity445.74455.09456.10472.96478.20440.11
Total Liabilities & Stockholders Equity672.44676.21638.09641.86643.61595.62
Book Value Per Share7.117.327.447.807.957.35
Tangible Book Value Per Share5.605.795.896.226.355.69
Full-Time Employees---979--
Price to Book Ratio18.586.384.073.545.005.13
Return on Assets-20.78-12.78-12.29-12.37-13.29-29.44
Return on Equity-29.59-18.16-16.79-16.43-17.58-38.22
Return on Invested Capital-6.60-8.14-5.63-5.083.77-7.78
Quick Ratio2.382.423.373.333.604.24
Current Ratio2.672.703.783.643.904.51

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-35.05-44.02-30.51-27.1420.39-39.33
Depreciation6.786.416.196.006.076.40
Other Funds (Non Cash)18.3418.4412.9416.30-31.6421.16
Funds from Operations-9.94-19.17-11.38-4.83-5.18-11.77
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital11.051.61-13.44-6.983.78-1.22
Cash from Operating Activities1.11-17.56-24.81-11.81-1.40-12.99
Capital Expenditures-9.76-7.99-9.97-12.43-9.16-4.14
Net Assets From Acquisitions0.00-5.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.002.500.00
Purchase or Sale of Investments-0.430.280.040.02-2.732.72
Purchase of Investments-13.23-4.72-20.51-21.14-2.73-4.93
Sale Or Maturity of Investments12.805.0020.5521.160.007.65
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-10.20-12.71-9.93-12.40-9.40-1.43
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock3.794.140.305.571.833.20
Repurchase of Common Pref Stock-0.01-0.01-0.00-0.00-0.00-0.01
Sale of Common Pref Stock3.794.150.305.581.833.20
Proceedsfrom Stock Options0.002.360.001.780.002.43
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities3.794.140.305.571.833.20
Exchange Rate Effect0.01-0.010.010.16-0.070.10
Net Change in Cash-5.29-26.13-34.44-18.48-9.04-11.11
Free Cash Flow-8.65-25.45-34.79-24.24-10.56-17.13

Revenue breakdown

Antibody Discovery2024: 20.33M 2025: 23.45M
Dna And Biopharma Libraries2024: 13.93M 2025: 11.18M
Ngs Tools2024: 169.13M 2025: 208.10M
Oligo Pools2024: 16.91M 2025: 20.23M
Synthetic Genes2024: 92.68M 2025: 113.60M
Americas2024: 193.88M 2025: 225.58M
Asia Pacific2024: 26.52M 2025: 26.75M
EMEA2024: 92.57M 2025: 124.24M
Total Biological Products, (No Diagnostic Substances) revenue2024: 312.97M 2025: 376.57M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3015.37%9.8M64.0M2.32M
2026-10-1515.95%10.2M64.0M2.14M
2026-09-3016.54%10.6M63.9M1.77M
2026-09-1519.62%12.5M63.7M1.71M
2026-08-3118.93%12.1M63.7M1.79M
2026-08-1422.22%14.1M63.5M1.78M
2026-07-3123.41%14.1M60.1M1.74M
2026-07-1523.65%14.1M59.7M1.75M
2026-06-3023.37%13.9M59.7M1.70M
2026-06-1529.62%17.7M59.6M1.48M
2026-05-2924.99%14.9M59.6M1.32M
2026-05-1527.83%16.6M59.6M1.28M
2026-04-3023.36%13.9M59.6M1.31M
2026-04-1524.77%14.5M58.6M1.29M
2026-03-3124.15%14.1M58.6M1.33M
2026-03-1321.95%12.9M58.6M1.30M
2026-02-2721.72%12.7M58.6M1.34M
2026-02-1322.20%13.0M58.6M1.50M
2026-01-3020.79%12.2M58.5M1.43M
2026-01-1521.38%12.5M58.5M1.52M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call75.0047.3050.300.002.7940.000.000.970-0.1420.013
call80.0042.5045.6094.902.5961.000.000.957-0.1810.017
call85.0037.8040.9051.222.2622.000.000.913-0.3420.030
call90.0033.1036.3039.002.17212.0012.000.880-0.4270.038
call95.0029.0032.100.002.0980.000.000.848-0.4790.045
call10024.8028.0029.001.99425.000.000.804-0.5570.053
call10521.0024.200.001.9310.000.000.756-0.6220.060
call11017.8020.7031.501.8512171.000.716-0.5790.065
call11514.6017.5017.801.8112062.000.650-0.6440.071
call12012.0013.8017.451.6391102.000.585-0.6690.074
call1259.6011.4012.501.6209.0011.000.519-0.6850.076
call1307.609.208.511.61448.0026.000.457-0.6870.076
call1356.308.909.001.59612314.000.397-0.6690.074
call1404.907.506.691.5671,1369.000.338-0.6220.070
call1453.704.704.801.5761255640.288-0.5840.065
call1502.753.803.651.5854561010.245-0.5410.060
call1551.604.203.601.72533318.000.231-0.5690.058
call1601.353.702.721.82148315.000.213-0.5740.055
call1650.903.403.001.8886256.000.194-0.5630.052
call1700.651.951.501.69023112.000.134-0.3960.041
call1750.252.101.331.7911,1106.000.128-0.4070.040
call1800.153.001.591.88751.005.000.123-0.4170.039
call1850.052.751.001.9802113.000.119-0.4270.038
call1900.051.050.601.80716512.000.079-0.2870.028
call1950.001.601.101.88625648.000.076-0.2920.027
call2000.101.000.551.92429645.000.069-0.2770.025
call2100.002.451.002.06638.000.000.065-0.2850.024
call2200.001.100.702.1991,0504.000.062-0.2920.023
call2300.001.000.302.3241300.000.060-0.2990.023
call2400.001.201.382.44229.000.000.058-0.3050.022
call2500.001.050.252.55442.003.000.056-0.3100.021
call2600.052.250.452.66027.000.000.054-0.3150.021
call2700.002.200.482.76134.000.000.052-0.3200.020
call2800.002.201.662.8576.000.000.051-0.3240.020
call2900.002.201.502.9492.000.000.050-0.3290.020
call3000.002.200.103.03713615.000.049-0.3330.019
put75.000.001.850.331.82210.001.00-0.030-0.1340.013
put80.000.000.650.551.74114122.00-0.043-0.1720.017
put85.000.451.650.761.95420.0016.00-0.087-0.3330.030
put90.000.702.501.601.94372.0029.00-0.120-0.4170.038
put95.001.553.202.301.85924.0011.00-0.152-0.4690.045
put1002.054.404.001.84282.0021.00-0.196-0.5460.053
put1053.105.804.401.81413.00564-0.244-0.6100.060
put1105.606.505.901.56133437.00-0.284-0.5660.065
put1157.408.407.801.54358533.00-0.350-0.6310.071
put1209.2010.809.861.532222452-0.415-0.6560.074
put12511.1013.4012.701.517968149-0.481-0.6710.076
put13014.4017.0015.301.510302615-0.543-0.6730.076
put13517.3019.7019.251.5033044.00-0.603-0.6540.074
put14021.0024.0022.901.6853155.00-0.662-0.6070.070
put14524.7027.0020.811.7166480.00-0.712-0.5680.065
put15028.6032.0028.401.7051252.00-0.755-0.5240.060
put15533.0035.5026.531.6092140.00-0.769-0.5520.058
put16037.3040.2036.801.7751,0744.00-0.787-0.5570.055
put16541.8044.6041.301.67526.001.00-0.806-0.5450.052
put17046.4048.9042.601.85134.000.00-0.866-0.3770.041
put17551.1054.3045.101.68923920.00-0.872-0.3870.040
put18056.0059.0056.001.9423700.00-0.877-0.3970.039
put18560.8063.9056.102.01120.000.00-0.881-0.4060.038
put19065.7068.7064.602.04865.000.00-0.921-0.2660.028
put19570.6073.6065.482.0761800.00-0.924-0.2710.027
put20075.5078.6070.122.18712.000.00-0.931-0.2550.025
put21085.5088.5077.102.31215.000.00-0.935-0.2620.024
put22095.4098.4051.242.4258.000.00-0.938-0.2680.023
put230105.3108.459.482.5613.000.00-0.940-0.2730.023
put240115.3118.31032.6536.000.00-0.942-0.2780.022
put250125.2128.70.002.7740.000.00-0.944-0.2820.021
put260135.2138.3124.33.0293.000.00-0.946-0.2860.021
put270144.9149.40.002.9980.000.00-0.948-0.2900.020
put280154.9159.4150.33.1031.000.00-0.949-0.2930.020
put290165.2168.2129.23.1630.000.00-0.950-0.2960.020
put300175.2178.20.003.2590.000.00-0.951-0.2990.019

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10SCHEDULE 13GSEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-054Statement of changes in beneficial ownership of securities2026-11-03SEC
2026-11-05SCHEDULE 13G/ASEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-10-274Statement of changes in beneficial ownership of securities2026-10-23SEC
2026-10-23144Filing for proposed sale of securities under Rule 144.SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-09144Filing for proposed sale of securities under Rule 144.SEC
2026-10-074Statement of changes in beneficial ownership of securities2026-10-05SEC
2026-10-05144Filing for proposed sale of securities under Rule 144.SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-01SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-054Statement of changes in beneficial ownership of securities2026-10-02SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC
2026-10-02144Filing for proposed sale of securities under Rule 144.SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11001.25M5
2026-100020.74M10
2026-090058.11M9
2026-080041.20M20
2026-0700436.44K2
2026-06005.75M10
2026-05008.34M21
2026-04001.39M8
2026-0300761.83K8
2026-02008.32M20
2026-01001.26M4
2025-1200199.71K7
2025-1100698.96K13

Institutional holders

Manager% owned
FMR LLC14.73%
BlackRock, Inc.9.37%
Artisan Partners Limited Partnership7.71%
ARK Investment Management LLC7.31%
PRICE T ROWE ASSOCIATES INC /MD/5.84%
STATE STREET CORP5.19%
VANGUARD PORTFOLIO MANAGEMENT LLC4.54%
VANGUARD CAPITAL MANAGEMENT LLC4.33%
EdgePoint Investment Group Inc.4.05%
FARALLON CAPITAL MANAGEMENT, L.L.C.3.43%

Funds

Fund% owned
ARK Innovation ETF3.23%
VANGUARD TOTAL STOCK MARKET INDEX FUND3.01%
iShares Russell 2000 ETF2.56%
State Street(R) SPDR(R) S&P(R) Biotech ETF2.36%
VANGUARD SMALL-CAP INDEX FUND2.18%
ARK Genomic Revolution ETF2.11%
T. Rowe Price New Horizons Fund, Inc.1.54%
Artisan Mid Cap Fund1.43%
Bridge Builder Small/Mid Cap Growth Fund1.39%
Invesco Discovery Fund1.27%

OakChart. TWST. Cached 15 minutes.